Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis

NCT02575625 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT02575625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02575625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
Lead sponsor
University Hospital, Tours
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
November 30, 2015
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver steatosis